These data indicate that MMTV-PyMT TICs undergo an EMT process with intermediate stages, which could be due to heterogeneous sub-populations within CD24+CD90+ cells and has been proposed recently also for human breast cancer TICs [26, 32–34]. This evidence concerns the gene CD24 and breast cancer.